Matthias Preusser

Young Oncologists Committee member

Address Medical University of Vienna
Department of Internal Medicine I & Comprehensive Cancer Center
Vienna
Country

Austria

Matthias Preusser

Matthias Preusser is an Associate Professor of Medicine and a consultant in Medical Oncology at the Medical University of Vienna. He serves as Coordinator of the CNS Tumours Unit at the Comprehensive Cancer Centre Vienna and is a Steering Committee member of the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumour Group. Prof Preusser is a member of the ESMO Young Oncologists Committee and the ESMO Fellowship and Awards Committee and belongs to the ESMO Faculty for CNS Tumours.

Prof Preusser received his medical training at the Medical University of Vienna and completed research and clinical visits at the German Cancer Center (DKFZ) in Heidelberg, Germany, and the Memorial Sloan-Kettering Cancer Center, New York, U.S.A. His research focuses on biomarkers and therapy in brain tumours. Prof Preusser has authored >160 research articles and is a co-author of the current edition of the World Health Organization (WHO) Classification of Brain Tumours.

We have asked Prof Preusser to tell us a bit more about himself and his involvement in the ESMO Young Oncologist Committee especially to get his tips on developing a productive career in medical oncology.

What is your main area of interest?

I have a special interest in Neurooncology and am part of several international research groups including the European Organization for Research and Treatment of Cancer Brain Tumour Group.

How do you spend your time?

I work as specialist in Internal Medicine at the Medical University of Vienna and the Comprehensive Cancer Centre Vienna. I am involved in clinical patient care, academic research and teaching of medical students. I run several translational and clinical research projects on primary and secondary brain tumours and coordinate the Internal Medicine training program at our university.

Could you tell us why you chose to become a medical oncologist?

I am fascinated and at the same time intimidated by the biology and course of cancer and want to contribute to fighting and eventually curing this devastating disease- both in the patients of today (by providing clinical care) and the patients of tomorrow (by doing research).

What does your involvement with ESMO and the Young Oncologists Committee (YOC) mean to you?

The involvement with ESMO provides me with the possibility to work and interact with international colleagues. I am very pleased to be able to contribute to the development of medical oncology in Europe through working on the projects of the Young Oncologists Committee. A strong network of well trained, committed and scientifically active young oncologists is necessary to maintain and further develop high quality cancer care in Europe.

Do you have some good advice you would like to share with your international colleagues?

As Aristotle said: The whole is more than the sum of its parts.